IPO Profile: Mediwound Ltd

Clal Biotechnology Industries owns 9,789,555 shares worth about $137 million at the IPO price.

11 April 2014•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.